DiscoverIllumina Genomics PodcastHomologous Recombination Deficiency (HRD) Testing in Ovarian Cancer
Homologous Recombination Deficiency (HRD) Testing in Ovarian Cancer

Homologous Recombination Deficiency (HRD) Testing in Ovarian Cancer

Update: 2022-11-11
Share

Description

Isabelle Ray-Coquard, MD, PhD, explains how comprehensive genomic profiling (CGP) simultaneously provides HRD and BRCA status in ovarian cancer patients. She presents the case of a patient who benefited from CGP testing for these biomarkers and shares the recent findings of the PAOLA-1 trial.
Comments 
loading
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Homologous Recombination Deficiency (HRD) Testing in Ovarian Cancer

Homologous Recombination Deficiency (HRD) Testing in Ovarian Cancer

Illumina Genomics Podcast